Natco Pharma informs about press release

03 Nov 2017 Evaluate

Natco Pharma has informed about press release titled ‘Natco’s marketing partner Alvogen first to market generic equivalent to oseltamivir phosphate powder for oral suspension in the USA’.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

898.80 -34.80 (-3.73%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×